STOCK TITAN

Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Castle Biosciences, Inc. (CSTL) receives the Top Workplaces USA award for the third year in a row, ranking 28th among 370 companies. The company is recognized for its exceptional workplace culture that prioritizes employee empowerment, trust, transparency, and authenticity. The award is attributed to the dedication of Castle's employees and their commitment to improving health through innovative tests that guide patient care.
Positive
  • None.
Negative
  • None.

Company honored for creating an exceptional, people-first culture that empowers employees and fosters trust, transparency and authenticity

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received a Top Workplaces USA award for the third consecutive year. The national award program by Energage and USA Today celebrates organizations that have built exceptional workplace cultures. Castle was ranked 28th among 370 participating U.S. companies with 500-999 employees.

“I am so proud to accept this award once again on behalf of our exceptional employees, to whom I credit this honor,” said Derek Maetzold, president and chief executive officer at Castle Biosciences. “At Castle, our work to improve health through innovative tests that guide patient care is vitally important, but it’s the people — our valued Castle team members — who make Castle special. We have worked hard to create a work environment that truly supports our employees’ needs by providing an inclusive and welcoming atmosphere, competitive compensation packages, industry-leading benefits and a healthy work/life balance. The feedback we receive from our employees each year via this survey allows us to continually evaluate and improve upon our strong company culture.”

Top Workplace designations are garnered solely through anonymous employee feedback gathered through a third-party survey administered by Energage. The confidential survey measures 15 culture drivers that are indicative of successful organizations, such as alignment, execution and connection. Castle’s survey participation rate of 95% and employee engagement score of 86% were both above the benchmark averages of 61% and 75%, respectively, for other similar healthcare companies participating in the Top Workplaces program.

In addition to the 2024 Top Workplaces USA award, the Company has earned several past national and regional awards in this program, including:

  • Top Workplaces Industry, 2023 (Healthcare, ranking third out of 84 firms)
  • Top Workplaces Culture Excellence, 2023 and 2022 (Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership, Purpose & Values, Employee Appreciation, Employee Well-Being, Professional Development)
  • Top Workplaces Houston, 2023, 2022 and 2021
  • Top Workplaces Arizona, 2023 and 2022

The comprehensive list of 2024 Top Workplaces USA can be found on USAToday.com.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

About Energage

Making the world a better place to work together.™

Energage is a purpose-driven technology company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces. Built on 17 years of culture research and the results from 27 million employees surveyed across more than 70,000 organizations, Energage delivers the most accurate competitive benchmark available. With access to a unique combination of patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture. For more information or to nominate your organization, visit energage.com or topworkplaces.com.

Investor Contact:

Camilla Zuckero

czuckero@castlebiosciences.com

Media Contact:

Allison Marshall

amarshall@castlebiosciences.com

Source: Castle Biosciences Inc.

Castle Biosciences received the Top Workplaces USA award for the third consecutive year.

Castle Biosciences ranked 28th among 370 U.S. companies with 500-999 employees.

Castle Biosciences prioritizes employee needs by offering inclusive and welcoming atmosphere, competitive compensation packages, industry-leading benefits, and a healthy work/life balance.

The award is based on anonymous employee feedback gathered through a third-party survey measuring 15 culture drivers such as alignment, execution, and connection.

Castle Biosciences had a survey participation rate of 95% and an employee engagement score of 86%, both above benchmark averages for similar healthcare companies.
Castle Biosciences Inc

NASDAQ:CSTL

CSTL Rankings

CSTL Latest News

CSTL Stock Data

Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
Health Technology, Health Services, Medical/Nursing Services

About CSTL

castle biosciences, inc. specializes in diagnostic tests for cancers. founded in 2008, the company goal has been to help advance the care for cancers through objective testing. our team works with outstanding members of the oncology community throughout the discovery, development and utilization of these tests. currently, castle biosciences has tests to help doctors treat cutaneous melanoma, uveal melanoma, esophageal adenocarcinoma, mesothelioma and glioma. we have active research programs in rectal cancer and soft tissue sarcoma, and anticipate tests for these and other under-served cancers to be available in the near future please visit us at www.castlebiosciences.com for more information on our company and products.